Social Media Ideas for Contract Development And Manufacturing Organization

Made Scientific, Pluristyx launch development and manufacturing partnership

Made Scientific Inc., a clinical- and commercial-stage cell therapy contract development and manufacturing organization (CDMO), and Pluristyx, a provider of cell (iPSC) platform te...

WACKER offers Contract Research Services (CRS) for nucleic acid-based pharmaceuticals

- - • The new CRS expand WACKER's offering for biotech and biopharmaceutical customers worldwide and complement Wacker Biotech's CDMO services. - - • The Munich team at the...

Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility

The manufacturing of highly potent compounds has been a core pillar of Shilpa’s identity, and this ADC drug substance facility adds a new sophisticated dimension to the Shilpa grou...

End-to-end: Curia drives supply and scale for steroid and hormonal therapies

Explore how Curia tackles steroid manufacturing complexity, from early development to scaled, end-to-end commercial supply. The post End-to-end: Curia drives supply and scale for s...

How Companies Evaluate CDMO Pharmaceutical Partners for Long-Term Success

Choosing a contract manufacturing partner is one of the most consequential decisions a […]

Caidya and Simbec-Orion unite in global CRO combo

Contract research organizations (CROs) Caidya and Simbec-Orion have united to create a new platform aimed at helping drug development programs accelerate and scale.

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs

For biopharma manufacturing at speed and scale, the future is flexible

Biopharma development has long trended toward specialized and personalized therapies such as cell and gene therapies, antibody-drug conjugates, and monoclonal antibodies (mAbs), am...

Oligonucleotide Therapeutic Industry Readies Itself to Move to the Next Phase

As synthetic oligonucleotide therapeutics become validated and feasible for commercial production, manufacturers are being urged to become familiar with the Chemistry, Manufacturin...

Wacker Expands Service Offerings with Launch of Contract Research for Nucleic Acid-Based Therapies

In addition to producing pDNA, RNA, and LNP formulations, Wacker’s CRS team offers construct design services, including plasmid and RNA construct design as well as RNA engineering...

<![CDATA[Catalent Announces Expanded Partnership with Nanoscope Therapeutics]]>

<![CDATA[Additive Manufacturing's Application in Pharma and Biotech]]>

5 Indian CDMO Stocks Benefiting from the Global Pharma Outsourcing Boom

Synopsis: Global pharmaceutical companies are rapidly diversifying their manufacturing supply chains as geopolitical tensions, regulatory changes and the proposed U.S. BIOSECURE Ac...

Viral vector production: How CDMOs influence late-stage development success

Explore how viral vector CDMOs improve late-stage cell and gene therapy success by reducing risk, variability, and complexity. The post Viral vector production: How CDMOs influence...

Peptistar Began Operation of the Asahi Kasei FO-MD System at Manufacturing Scale

FO utilizes an osmotic pressure difference across a membrane to remove water from liquids, achieving highly concentrated API solutions under mild conditions. MD leverages a vapor p...

Creative Biolabs Expands Liposome Development Services with Functional and Stimuli-Responsive Formulation Solutions

Advanced liposome engineering services help researchers improve drug targeting, stability, and controlled release for next-generation therapeutics.

Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell Engineering

The aim of the partnership is to provide a platform delivering high-end performance with an optimal cost-of-goods and price-per-dose model to ease scale-up, commercial strategy, an...

Unlocking more value from mature drug products through strategic outsourcing

See how strategic outsourcing can maximize value and reduce costs for mature drug portfolios.

Cellares and Sonoma Biotherapeutics Agree to Automate Engineered Treg Cell Therapy Manufacturing

Cellares plans to translate the manufacturing of SonomaBio’s SBT-77-7101 onto its Cell Shuttle and automate in-process and release testing through the Cell Q quality control syste...

Analytical Challenges for Antibody-Drug Conjugate (ADC) Manufacturing

This collection of articles and expert perspectives explores the critical challenges shaping ADC development today, from analytical strategy and impurity control to linker technolo...

Yangi Commissions Cellera® Platform at European Converter Site

The Cellera platform was industrialized in collaboration with GDM, a Coesia company, and AP&T, leveraging proven industrial machine execution to ensure reliable production and...

<![CDATA[DARPA's Role in Bringing Manufacturing Back to the US]]>

Beyond Rigid Platforms: Adaptive Adenoviral Platform De-Risks Development to GMP

Rigid adenoviral platforms can derail GMP progress. Learn how adaptive, adenovirus-specific strategies reduce risk from development to scale.